ACADIA Pharmaceuticals
ACAD
#4034
Rank
S$3.81 B
Marketcap
S$22.07
Share price
-2.73%
Change (1 day)
-28.27%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): S$2.73

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$2.75. In 2025 the company made an earnings per share (EPS) of S$2.99 an increase over its 2024 EPS that were of S$1.75.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$2.73-8.62%
2025S$2.9970.59%
2024S$1.75-457.89%
2023S-$0.49-71.64%
2022S-$1.7327.62%
2021S-$1.35-41.67%
2020S-$2.3212.5%
2019S-$2.06-17.95%
2018S-$2.52-17.02%
2017S-$3.030.43%
2016S-$3.0243.56%
2015S-$2.1073.4%
2014S-$1.21
2012S-$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S-$5.96-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA